Luigi Mangione admits shooting UnitedHealthcare CEO as federal case ends without trial

Luigi Mangione pleaded guilty on Friday, August 14, to two federal stalking charges connected to the killing of UnitedHealthcare Chief Executive Officer Brian Thompson, publicly acknowledging in federal court that he tracked the insurance executive and fatally shot him in Manhattan in December 2024. The guilty plea eliminates the need for a federal trial and leaves the 28-year-old facing the possibility of life imprisonment when he is sentenced on December 18. Federal prosecutors said there was no plea agreement and that they intend to seek the maximum sentence, meaning Mangione received no guaranteed concession for admitting responsibility. The development has also immediately complicated his separate New York state murder prosecution, with his lawyers moving to dismiss most of that case on double-jeopardy grounds.

The hearing represents one of the most significant turns in a criminal case that has attracted extraordinary national attention since Thompson was killed outside a Manhattan hotel on December 4, 2024. Mangione had previously pleaded not guilty and was preparing for separate federal and state proceedings, but his admission now establishes criminal responsibility in the federal case while shifting much of the legal uncertainty toward whether New York can continue prosecuting him for murder.

Luigi Mangione admits targeting Brian Thompson before the December 2024 shooting

During the federal hearing in Manhattan, Mangione acknowledged that he deliberately pursued Thompson and traveled to New York intending to kill him. He told the court that he had contacted UnitedHealthcare before its 2024 investor conference while presenting himself as an investor managing tens of billions of dollars, using that approach to obtain information about the event and the executives expected to attend.

Mangione also acknowledged manufacturing part of the weapon using a 3D printer before traveling to New York. Thompson, who was 50 and headed UnitedHealth Group’s UnitedHealthcare insurance business, was shot outside the New York Hilton Midtown as he was heading toward the company’s investor conference on the morning of December 4. Surveillance footage of the attack and the subsequent five-day search for the gunman rapidly turned the killing into one of the country’s most closely followed criminal cases.

Mangione was arrested on December 9 at a McDonald’s restaurant in Altoona, Pennsylvania, after police were alerted to a customer resembling the wanted suspect. Investigators said they recovered a 3D-printed pistol that they later linked to the shooting as well as a notebook containing writings about targeting a health insurance executive. Courts overseeing both the federal and New York cases subsequently ruled that significant portions of that evidence could be presented against him.

The federal charges to which Mangione pleaded guilty concern interstate stalking resulting in death and stalking through interstate facilities resulting in death. Each carries the possibility of life imprisonment, and United States District Judge Margaret Garnett scheduled sentencing for December 18. Prosecutors have already made clear that they plan to seek a life sentence.

No plea deal means Mangione still faces the possibility of spending his life in federal prison

A notable aspect of the August 14 hearing is that Mangione did not receive a negotiated plea agreement from federal prosecutors. Both sides confirmed that prosecutors had made no concessions or accommodations in exchange for the guilty plea, although Garnett can consider his decision to accept responsibility when determining the eventual sentence.

That makes the decision legally significant because Mangione has surrendered his opportunity to contest the federal stalking case at trial without securing a predetermined sentencing outcome. The maximum possible punishment remains life imprisonment, and prosecutors have said that is precisely what they will request in December. Thompson’s family described the guilty plea as an important step toward accountability while emphasizing that the remaining legal proceedings have not concluded.

The federal case had once carried the possibility of capital punishment. Federal prosecutors initially charged Mangione with murder and a firearms offense that could have supported a death sentence, but Garnett dismissed those charges in January 2026 after finding that they were legally incompatible with the remaining stalking counts. That ruling removed the death penalty from the federal prosecution while leaving Mangione exposed to a potential life sentence.

The New York prosecution had undergone a similar narrowing. State prosecutors originally included terrorism-related murder counts, but a judge dismissed those charges in September 2025 after rejecting the argument that the killing met the legal requirements for terrorism. Mangione nevertheless continues to face second-degree murder and additional state charges unless his latest dismissal effort succeeds.

Federal guilty plea creates a new double-jeopardy fight before Mangione’s September murder trial

The most consequential unanswered question now concerns Mangione’s state prosecution. His New York murder trial is scheduled to begin on September 8, but immediately after the federal guilty plea his attorneys filed a motion seeking to have most of the state charges dismissed under New York’s protections against double jeopardy.

The defense argues that Mangione should not be prosecuted and punished twice for what it characterizes as the same underlying conduct. Although the federal convictions are technically stalking offenses rather than murder charges, both require prosecutors to establish conduct involving an intent to kill Thompson and resulting in his death. Mangione’s attorneys contend that proceeding with a separate state murder case after he has already admitted and been convicted over the killing would violate New York law and his constitutional rights.

The Manhattan District Attorney’s Office has indicated that it intends to oppose that argument and continue seeking a state conviction. New York’s double-jeopardy rules contain exceptions when different offenses involve materially different legal elements or are designed to prevent substantially different harms, leaving the courts to determine whether the federal stalking convictions and state murder prosecution are sufficiently distinct.

The timing could make the issue particularly important. Jury selection in the state case has been scheduled for September 8, meaning the court may need to address the defense challenge quickly or determine whether the trial timetable should change while the double-jeopardy question is litigated. A dismissal would dramatically narrow Mangione’s remaining criminal exposure, while a ruling allowing the case to proceed could still subject him to a second major trial despite Friday’s federal admission.

Mangione links his actions to health insurance frustrations but case remains centered on a deliberate killing

Mangione used his court statement to describe years of serious back pain and frustration navigating the health insurance system. He said those experiences preceded his decision to target Thompson, although UnitedHealthcare and police have previously said Mangione himself was not a UnitedHealthcare customer.

The killing nevertheless became intertwined with a wider national argument over medical bills, rejected insurance claims and Americans’ frustration with health insurers. Thompson’s death generated condemnation from public officials and the healthcare industry while Mangione simultaneously attracted a highly visible group of supporters, particularly online, who portrayed the case as symbolic of anger toward the United States healthcare system.

That broader debate does not alter the criminal conduct Mangione admitted in court. His guilty plea establishes that he deliberately sought information about Thompson’s whereabouts, manufactured part of a firearm, traveled to New York intending to kill him and then carried out the shooting. Federal and New York officials have stressed that dissatisfaction with healthcare or insurance practices cannot legally justify violence against an individual executive.

The distinction matters because much of the public attention surrounding the case has focused on what the killing supposedly represented rather than the underlying criminal prosecution. Mangione’s August 14 admission significantly reduces uncertainty over whether he committed the shooting while leaving courts to decide how he should be punished and whether New York is entitled to prosecute him separately.

Brian Thompson killing now enters a new phase focused on sentencing and the New York prosecution

Mangione’s federal case is effectively moving from questions of guilt to punishment. Garnett will determine his sentence on December 18, with prosecutors seeking life imprisonment and the defense likely to argue that his guilty plea, acceptance of responsibility and other mitigating factors justify a lesser sentence.

Before then, however, the September state case could become the more immediate legal battleground. If Mangione succeeds in invoking New York’s double-jeopardy protections, the guilty plea that exposed him to life imprisonment federally may also eliminate or substantially reduce the threat of a second murder prosecution. If the challenge fails, he could still go before a New York jury only weeks after formally admitting in federal court that he killed Thompson.

The guilty plea therefore resolves one major part of the case while opening another. Nearly two years after Thompson’s killing triggered a nationwide manhunt and a broader argument about anger toward the health insurance industry, the central legal dispute has shifted away from identifying responsibility and toward the consequences of Mangione’s admission.

Key takeaways from Luigi Mangione’s guilty plea in the Brian Thompson killing

• Luigi Mangione pleaded guilty on August 14 to two federal stalking charges arising from the December 2024 killing of UnitedHealthcare Chief Executive Officer Brian Thompson.
• Mangione admitted that he deliberately tracked Thompson, traveled to New York intending to kill him and fatally shot the executive outside a Manhattan hotel.
• The guilty plea was entered without a plea agreement, and federal prosecutors said they made no concessions in return for Mangione accepting responsibility.
• Prosecutors intend to seek life imprisonment when Mangione is sentenced in federal court on December 18.
• Mangione no longer faces a federal death sentence because the murder and related firearms counts were dismissed by a judge in January 2026.
• His lawyers have now asked a New York court to dismiss most of his remaining state charges on double-jeopardy grounds.
• The Manhattan District Attorney’s Office intends to oppose the dismissal request and continue pursuing its state murder case.
• Mangione’s New York murder trial is currently scheduled to begin on September 8, making the double-jeopardy dispute the next major legal development to watch.